Article abstract
Nature Medicine 13, 423 - 431 (2007)
Published online: 25 March 2007 | doi:10.1038/nm1564
Myelin-specific regulatory T cells accumulate in the CNS but fail to control autoimmune inflammation
Thomas Korn1, Jayagopala Reddy1, Wenda Gao2, Estelle Bettelli1, Amit Awasthi1, Troels R Petersen3, B Thomas Bäckström3, Raymond A Sobel4, Kai W Wucherpfennig5, Terry B Strom2, Mohamed Oukka1,6 & Vijay K Kuchroo1,6
Abstract
Treatment with ex vivo–generated regulatory T cells (T-reg) has been regarded as a potentially attractive therapeutic approach for autoimmune diseases. However, the dynamics and function of T-reg in autoimmunity are not well understood. Thus, we developed Foxp3gfp knock-in (Foxp3gfp.KI) mice and myelin oligodendrocyte glycoprotein (MOG)35–55/IAb (MHC class II) tetramers to track autoantigen-specific effector T cells (T-eff) and T-reg in vivo during experimental autoimmune encephalomyelitis (EAE), an animal model for multiple sclerosis. MOG tetramer–reactive, Foxp3+ T-reg expanded in the peripheral lymphoid compartment and readily accumulated in the central nervous system (CNS), but did not prevent the onset of disease. Foxp3+ T cells isolated from the CNS were effective in suppressing naive MOG-specific T cells, but failed to control CNS-derived encephalitogenic T-eff that secreted interleukin (IL)-6 and tumor necrosis factor (TNF). Our data suggest that in order for CD4+Foxp3+ T-reg to effectively control autoimmune reactions in the target organ, it may also be necessary to control tissue inflammation.
- Center for Neurologic Diseases, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts 02115, USA.
- Transplant Research Center, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts 02115, USA.
- Malaghan Institute of Medical Research, P.O. Box 7060, Wellington South, New Zealand.
- Laboratory Service, Veterans Affairs Health Care System, Palo Alto, California 94304, and Department of Pathology, Stanford University School of Medicine, Stanford, California 94305, USA.
- Department of Cancer Immunology & AIDS, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts 02115, USA.
- These authors contributed equally to this work.
Correspondence to: Mohamed Oukka1,6 e-mail: moukka@rics.bwh.harvard.edu
Correspondence to: Vijay K Kuchroo1,6 e-mail: vkuchroo@rics.bwh.harvard.edu
MORE ARTICLES LIKE THIS
These links to content published by NPG are automatically generated.
NEWS AND VIEWS
T effectors outfox T regulators in autoimmunityNature Medicine News and Views (01 Apr 2007)
T effectors outfox T regulators in autoimmunityNature Medicine News and Views (01 Apr 2007)
See all 3 matches for News And ViewsRESEARCH
Myelin-specific regulatory T cells accumulate in the CNS but fail to control autoimmune inflammationNature Medicine Article (01 Apr 2007)
Myelin-specific regulatory T cells accumulate in the CNS but fail to control autoimmune inflammationNature Medicine Article
See all 61 matches for Research
